{
  "name": "Scribe Therapeutics, Inc.",
  "legal_name": "Scribe Therapeutics, Inc.",
  "ticker": "SCTX",
  "tickers": [
    "SCTX"
  ],
  "cik": "0001853921",
  "page_url": "https://steadybase.io/company/scribe-therapeutics-inc/",
  "markdown_url": "https://steadybase.io/company/scribe-therapeutics-inc.md",
  "json_url": "https://steadybase.io/company/scribe-therapeutics-inc.json",
  "as_of": "2026-11-21",
  "last_filed": "2026-11-12",
  "industry": {
    "sic": "2836",
    "description": "Biological Products, (No Diagnostic Substances)"
  },
  "headquarters": {
    "city": "Alameda",
    "state": "CA",
    "country": "US"
  },
  "exchanges": [
    "Nasdaq"
  ],
  "fiscal_year_end": "December 31",
  "filer_category": "Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company",
  "state_of_incorporation": "DE",
  "website": "scribetx.com",
  "investor_relations_url": "https://investors.scribetx.com/",
  "linkedin_company_url": "https://www.linkedin.com/company/scribe-therapeutics",
  "summary": {
    "text": "We’re unlocking the future of medicine with CRISPR-based therapeutics that are safe and effective enough to transform everyone's lifetime risk for disease.",
    "section": "Company website description",
    "period_end": "2026-11-07",
    "source_url": "https://www.scribetx.com/"
  },
  "key_facts": [
    {
      "key": "shares_outstanding",
      "label": "Shares outstanding",
      "value": 18937519,
      "unit": "shares",
      "period_end": "2026-11-06",
      "form": "10-Q",
      "filed": "2026-11-12",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1853921/000119312526458503/0001193125-26-458503-index.html",
      "text": "Shares outstanding: 18,937,519 as of Nov 6, 2026 (10-Q filed Nov 12, 2026)."
    }
  ],
  "metrics": {},
  "next_earnings": {
    "date": "2026-12-02",
    "confidence": "medium",
    "webcast_url": null
  },
  "people": [
    {
      "name": "Benjamin L. Oakes",
      "title": "President, CEO",
      "role": "both",
      "linkedin_url": "https://linkedin.com/in/benjaminloakes",
      "form": "4",
      "filed": "2026-07-27",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1853921/000212781426000004/0002127814-26-000004-index.htm"
    },
    {
      "name": "David Parrot",
      "title": "Chief Financial Officer",
      "role": "officer",
      "linkedin_url": "https://linkedin.com/in/davidlparrot",
      "form": "4",
      "filed": "2026-07-27",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1853921/000212790826000004/0002127908-26-000004-index.htm"
    },
    {
      "name": "Svetlana Lucas",
      "title": "Chief Business Officer",
      "role": "officer",
      "linkedin_url": null,
      "form": "4",
      "filed": "2026-07-27",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1853921/000178129226000007/0001781292-26-000007-index.htm"
    }
  ],
  "events_8k": [
    {
      "filed": "2026-11-12",
      "items": [
        {
          "item": "2.02",
          "label": "Results of operations and financial condition (earnings release)",
          "signal": "earnings"
        },
        {
          "item": "9.01",
          "label": "Financial statements and exhibits",
          "signal": "exhibits"
        }
      ],
      "source_url": "https://www.sec.gov/Archives/edgar/data/1853921/000119312526458486/sctx-20261112.htm"
    },
    {
      "filed": "2026-09-02",
      "items": [
        {
          "item": "2.02",
          "label": "Results of operations and financial condition (earnings release)",
          "signal": "earnings"
        },
        {
          "item": "9.01",
          "label": "Financial statements and exhibits",
          "signal": "exhibits"
        }
      ],
      "source_url": "https://www.sec.gov/Archives/edgar/data/1853921/000119312526380184/sctx-20260902.htm"
    },
    {
      "filed": "2026-07-27",
      "items": [
        {
          "item": "5.03",
          "label": "Amendments to articles or bylaws; change in fiscal year",
          "signal": "governance"
        },
        {
          "item": "9.01",
          "label": "Financial statements and exhibits",
          "signal": "exhibits"
        }
      ],
      "source_url": "https://www.sec.gov/Archives/edgar/data/1853921/000119312526318263/d141508d8k.htm"
    }
  ],
  "insider_trades": [
    {
      "owner": "Ventures LLC Avoro",
      "role": "Director",
      "action": "bought",
      "code": "P",
      "shares": 2391238,
      "value_usd": 36259761,
      "date": "2026-07-28",
      "filed": "2026-07-28",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1853921/000090266426003270/0000902664-26-003270-index.htm"
    },
    {
      "owner": "Behzad Aghazadeh",
      "role": "Director",
      "action": "bought",
      "code": "P",
      "shares": 2391238,
      "value_usd": 36259761,
      "date": "2026-07-28",
      "filed": "2026-07-28",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1853921/000090266426003270/0000902664-26-003270-index.htm"
    },
    {
      "owner": "Capital Advisors LLC Avoro",
      "role": "Director",
      "action": "bought",
      "code": "P",
      "shares": 2391238,
      "value_usd": 36259761,
      "date": "2026-07-28",
      "filed": "2026-07-28",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1853921/000090266426003270/0000902664-26-003270-index.htm"
    },
    {
      "owner": "Carl L. Gordon",
      "role": "Director",
      "action": "bought",
      "code": "P",
      "shares": 1000000,
      "value_usd": 15000000,
      "date": "2026-07-27",
      "filed": "2026-07-29",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1853921/000094787126000734/0000947871-26-000734-index.htm"
    },
    {
      "owner": "Capital GP VIII LLC OrbiMed",
      "role": "Director",
      "action": "bought",
      "code": "P",
      "shares": 1000000,
      "value_usd": 15000000,
      "date": "2026-07-27",
      "filed": "2026-07-29",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1853921/000094787126000733/0000947871-26-000733-index.htm"
    },
    {
      "owner": "Advisors Llc Orbimed",
      "role": "Director",
      "action": "bought",
      "code": "P",
      "shares": 1000000,
      "value_usd": 15000000,
      "date": "2026-07-27",
      "filed": "2026-07-29",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1853921/000094787126000733/0000947871-26-000733-index.htm"
    },
    {
      "owner": "David Parrot",
      "role": "Chief Financial Officer",
      "action": "bought",
      "code": "P",
      "shares": 2666,
      "value_usd": 39990,
      "date": "2026-07-23",
      "filed": "2026-07-27",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1853921/000212790826000004/0002127908-26-000004-index.htm"
    },
    {
      "owner": "Svetlana Lucas",
      "role": "Chief Business Officer",
      "action": "bought",
      "code": "P",
      "shares": 3000,
      "value_usd": 45000,
      "date": "2026-07-23",
      "filed": "2026-07-27",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1853921/000178129226000007/0001781292-26-000007-index.htm"
    }
  ],
  "quotes": [],
  "latest_filings": [
    {
      "form": "8-K",
      "filed": "2026-09-02",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1853921/000119312526380184/sctx-20260902.htm"
    },
    {
      "form": "10-Q",
      "filed": "2026-09-02",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1853921/000119312526380191/sctx-20260630.htm"
    }
  ],
  "source": "SEC EDGAR filings, read by Steadybase. Every value links to the filing it came from."
}